MICHAEL FRUMOVITZ to Humans
This is a "connection" page, showing publications MICHAEL FRUMOVITZ has written about Humans.
Connection Strength
1.212
-
Neuroendocrine neoplasms of the ovary: a review of 63 cases. Int J Gynecol Cancer. 2024 Apr 01; 34(4):566-573.
Score: 0.018
-
PET/CT scan improves detection of metastatic disease compared with CT scan alone in women with high-grade neuroendocrine cervical cancer: a NeCTuR study. Int J Gynecol Cancer. 2023 11 06; 33(11):1690-1694.
Score: 0.018
-
Clinicopathologic characteristics, oncologic outcomes, and prognostic factors in neuroendocrine cervical carcinoma: a Neuroendocrine Cervical Tumor Registry study. Int J Gynecol Cancer. 2023 09 04; 33(9):1359-1369.
Score: 0.018
-
Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated Cancers. Oncologist. 2023 07 05; 28(7):618-623.
Score: 0.017
-
Secondary Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy for Advanced or Recurrent Mucinous Ovarian Cancer. Obstet Gynecol. 2023 05 01; 141(5):1019-1023.
Score: 0.017
-
Association of nivolumab and niraparib in the management of neuroendocrine cancer of the cervix. Int J Gynecol Cancer. 2023 04 03; 33(4):623-627.
Score: 0.017
-
Open radical hysterectomy: The new standard of care in early-stage cervical cancer. BJOG. 2023 07; 130(8):851-855.
Score: 0.017
-
The role of postoperative radiation after radical hysterectomy for women with early-stage neuroendocrine carcinoma of the cervix: A meta-analysis. Gynecol Oncol. 2023 03; 170:328-332.
Score: 0.017
-
RB1 alteration and poor prognosis in women with high-grade neuroendocrine carcinoma of the uterine cervix: a NeCTuR study. J Gynecol Oncol. 2023 07; 34(4):e50.
Score: 0.017
-
Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in patients with recurrent high-grade neuroendocrine cervical cancer: a Neuroendocrine Cervical Tumor Registry (NeCTuR) study. Am J Obstet Gynecol. 2023 04; 228(4):445.e1-445.e8.
Score: 0.017
-
Advanced stage (FIGO IVB) neuroendocrine cervical carcinoma. Int J Gynecol Cancer. 2022 11 07; 32(11):1469-1474.
Score: 0.017
-
Definitive pelvic radiation therapy improves survival in stage IVB neuroendocrine cervical carcinoma: A NeCTuR study. Gynecol Oncol. 2022 06; 165(3):530-537.
Score: 0.016
-
Early-stage, high-grade neuroendocrine cervical carcinoma. Int J Gynecol Cancer. 2021 08; 31(8):1179-1183.
Score: 0.015
-
Comparison of Internal Patient Satisfaction Scores at a Cancer Center With Star Ratings on Online Physician-Rating Websites. JCO Oncol Pract. 2021 08; 17(8):e1181-e1188.
Score: 0.015
-
Surgical staging, the meaning of life, and other existential ponderings. Int J Gynecol Cancer. 2020 12; 30(12):1862-1863.
Score: 0.014
-
Evaluation of PARP and PDL-1 as potential therapeutic targets for women with high-grade neuroendocrine carcinomas of the cervix. Int J Gynecol Cancer. 2020 09; 30(9):1303-1307.
Score: 0.014
-
Comparative genomics of high grade neuroendocrine carcinoma of the cervix. PLoS One. 2020; 15(6):e0234505.
Score: 0.014
-
Phase II study of pembrolizumab efficacy and safety in women with recurrent small cell neuroendocrine carcinoma of the lower genital tract. Gynecol Oncol. 2020 09; 158(3):570-575.
Score: 0.014
-
Quality of life in patients with cervical cancer after open versus minimally invasive radical hysterectomy (LACC): a secondary outcome of a multicentre, randomised, open-label, phase 3, non-inferiority trial. Lancet Oncol. 2020 06; 21(6):851-860.
Score: 0.014
-
A phase III study of transdermal granisetron versus oral ondansetron for women with gynecologic cancers receiving pelvic chemoradiation. Support Care Cancer. 2021 Jan; 29(1):213-222.
Score: 0.014
-
Encouraging worldwide adoption of sentinel lymph node biopsies for gynecologic malignancies. Int J Gynecol Cancer. 2020 03; 30(3):281-282.
Score: 0.014
-
International Gynecologic Cancer Society 2019 meeting summary. Int J Gynecol Cancer. 2020 02; 30(2):167-173.
Score: 0.014
-
Effects of Gastrointestinal-Type Chemotherapy in Women With Ovarian Mucinous Carcinoma. Obstet Gynecol. 2019 12; 134(6):1253-1259.
Score: 0.013
-
Updates and management algorithm for neuroendocrine tumors of the uterine cervix. Int J Gynecol Cancer. 2019 07; 29(6):986-995.
Score: 0.013
-
Reproductive counseling and pregnancy outcomes after radical trachelectomy for early stage cervical cancer. J Gynecol Oncol. 2019 May; 30(3):e45.
Score: 0.013
-
Tailoring adjuvant treatment in patients with uterine cancer - Authors' reply. Lancet Oncol. 2018 12; 19(12):e656.
Score: 0.013
-
Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial. Lancet Oncol. 2018 10; 19(10):1394-1403.
Score: 0.012
-
Accuracy of Intraoperative Frozen Section Diagnosis of Borderline Ovarian Tumors by Hospital Type. J Minim Invasive Gynecol. 2019 01; 26(1):87-93.
Score: 0.012
-
Radical Hysterectomy and Age: Outcomes Comparison Based on a Minimally Invasive vs an Open Approach. J Minim Invasive Gynecol. 2018 Nov - Dec; 25(7):1224-1230.
Score: 0.012
-
Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer. Gynecol Oncol. 2017 04; 145(1):96-101.
Score: 0.011
-
Sentinel Lymph Node Biopsy for Cervical Cancer Patients - What's It Gonna Take? Gynecol Oncol. 2017 01; 144(1):3-4.
Score: 0.011
-
Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix. Gynecol Oncol. 2017 Jan; 144(1):46-50.
Score: 0.011
-
Patterns of recurrence and survival in neuroendocrine cervical cancer. Gynecol Oncol. 2016 Dec; 143(3):552-557.
Score: 0.011
-
Role of cervical cytology in surveillance after radical trachelectomy for cervical cancer. Gynecol Oncol. 2016 08; 142(2):283-5.
Score: 0.011
-
Sequencing of mutational hotspots in cancer-related genes in small cell neuroendocrine cervical cancer. Gynecol Oncol. 2016 06; 141(3):588-591.
Score: 0.010
-
Small- and Large-Cell Neuroendocrine Cervical Cancer. Oncology (Williston Park). 2016 Jan; 30(1):70, 77-8, 93.
Score: 0.010
-
Challenges in the diagnosis and management of cervical neuroendocrine carcinoma. Expert Rev Anticancer Ther. 2015; 15(7):805-10.
Score: 0.010
-
Optimizing sentinel node identification: a step toward novel tools and improved strategies--exciting times are here! J Minim Invasive Gynecol. 2015 Feb; 22(2):153-4.
Score: 0.010
-
Sentinel nodes in cervical cancer: surgical innovation outside the ivory towers. Ann Surg Oncol. 2015 Jun; 22(6):1759-60.
Score: 0.010
-
Morbid obesity as an independent risk factor for disease-specific mortality in women with cervical cancer. Obstet Gynecol. 2014 Dec; 124(6):1098-1104.
Score: 0.010
-
Clinically significant endometrial cancer risk following a diagnosis of complex atypical hyperplasia. Gynecol Oncol. 2014 Dec; 135(3):451-4.
Score: 0.009
-
Laparoscopic supracervical hysterectomy with morcellation: should it stay or should it go? J Minim Invasive Gynecol. 2015 Feb; 22(2):185-92.
Score: 0.009
-
Physician pain and discomfort during minimally invasive gynecologic cancer surgery. Gynecol Oncol. 2014 Aug; 134(2):243-7.
Score: 0.009
-
Mucinous tumors of the ovary: current thoughts on diagnosis and management. Curr Oncol Rep. 2014 Jun; 16(6):389.
Score: 0.009
-
Sentinel lymph node evaluation in women with cervical cancer. J Minim Invasive Gynecol. 2014 Jul-Aug; 21(4):540-5.
Score: 0.009
-
A case for caution in the pursuit of the sentinel node in women with endometrial carcinoma. Gynecol Oncol. 2014 Feb; 132(2):275-9.
Score: 0.009
-
Successful laparoscopic removal of adnexal mass in a patient with a large ventral hernia. J Minim Invasive Gynecol. 2014 May-Jun; 21(3):325-6.
Score: 0.009
-
Use of social media to conduct a cross-sectional epidemiologic and quality of life survey of patients with neuroendocrine carcinoma of the cervix: a feasibility study. Gynecol Oncol. 2014 Jan; 132(1):149-53.
Score: 0.009
-
Lymphadenectomy in locally advanced cervical cancer study (LiLACS): Phase III clinical trial comparing surgical with radiologic staging in patients with stages IB2-IVA cervical cancer. J Minim Invasive Gynecol. 2014 Jan-Feb; 21(1):3-8.
Score: 0.009
-
Laparoscopic hysterectomy for endometrial cancer: an established benefit no longer in question. J Minim Invasive Gynecol. 2013 Jul-Aug; 20(4):401-3.
Score: 0.009
-
Anatomic location of PET-positive aortocaval nodes in patients with locally advanced cervical cancer: implications for surgical staging. Int J Gynecol Cancer. 2012 Sep; 22(7):1203-7.
Score: 0.008
-
"Triple injection" lymphatic mapping technique to determine if parametrial nodes are the true sentinel lymph nodes in women with cervical cancer. Gynecol Oncol. 2012 Dec; 127(3):467-71.
Score: 0.008
-
Utility of conization with frozen section for intraoperative triage prior to definitive hysterectomy. Gynecol Oncol. 2012 Nov; 127(2):307-11.
Score: 0.008
-
Rhabdomyosarcoma of the cervix in adult women and younger patients. Gynecol Oncol. 2012 Sep; 126(3):351-6.
Score: 0.008
-
Minimally invasive surgical approaches for patients with endometrial cancer. Clin Obstet Gynecol. 2011 Jun; 54(2):226-34.
Score: 0.007
-
Balancing fertility and oncologic outcomes: can we have our cake and eat it too? Ann Surg Oncol. 2011 Jan; 18(1):10-1.
Score: 0.007
-
Outcomes of patients undergoing radical hysterectomy for cervical cancer of high-risk histological subtypes. Int J Gynecol Cancer. 2011 Jan; 21(1):123-7.
Score: 0.007
-
Primary malignant melanoma of the vagina. Obstet Gynecol. 2010 Dec; 116(6):1358-1365.
Score: 0.007
-
Laparoscopic total hysterectomy vs supracervical hysterectomy: turn, turn, turn. J Minim Invasive Gynecol. 2010 Nov-Dec; 17(6):669-70.
Score: 0.007
-
Unmasking the complexities of mucinous ovarian carcinoma. Gynecol Oncol. 2010 Jun; 117(3):491-6.
Score: 0.007
-
Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer. Obstet Gynecol. 2009 Jul; 114(1):93-99.
Score: 0.007
-
Gallbladder carcinoma presenting as a pelvic mass with elevated serum testosterone: a case report. J Reprod Med. 2009 Apr; 54(4):259-60.
Score: 0.006
-
Radical hysterectomy in obese and morbidly obese women with cervical cancer. Obstet Gynecol. 2008 Oct; 112(4):899-905.
Score: 0.006
-
Laparoscopy training in gynecologic oncology fellowship programs. Gynecol Oncol. 2008 Nov; 111(2):197-201.
Score: 0.006
-
Lymphatic mapping and sentinel lymph node detection in women with cervical cancer. Gynecol Oncol. 2008 Sep; 110(3 Suppl 2):S17-20.
Score: 0.006
-
Fertility preservation in patients with early cervical cancer: radical trachelectomy. Gynecol Oncol. 2008 Sep; 110(3 Suppl 2):S25-8.
Score: 0.006
-
Laparoscopic and robotic techniques for radical hysterectomy in patients with early-stage cervical cancer. Gynecol Oncol. 2008 Sep; 110(3 Suppl 2):S21-4.
Score: 0.006
-
Is lymphatic mapping in uterine cancer feasible? Ann Surg Oncol. 2008 Jul; 15(7):1815-7.
Score: 0.006
-
Lymphatic mapping and sentinel node biopsy in vulvar, vaginal, and cervical cancers. Oncology (Williston Park). 2008 Apr 30; 22(5):529-36; discussion 538-9, 542-3.
Score: 0.006
-
Puntambekar et Al. Laparoscopic total radical hysterectomy by the Pune technique: our experience of 248 cases. J Minim Invasive Gynecol. 2008 Mar-Apr; 15(2):254-5; author reply 255.
Score: 0.006
-
Lymphatic mapping and sentinel lymph node detection in women with vaginal cancer. Gynecol Oncol. 2008 Mar; 108(3):478-81.
Score: 0.006
-
Comparison of total laparoscopic and abdominal radical hysterectomy for patients with early-stage cervical cancer. Obstet Gynecol. 2007 Jul; 110(1):96-102.
Score: 0.006
-
Laparoscopic extraperitoneal para-aortic lymphadenectomy. Gynecol Oncol. 2007 Aug; 106(2):433-4; author reply 435.
Score: 0.006
-
Vascular endothelial growth factor (VEGF) pathway as a therapeutic target in gynecologic malignancies. Gynecol Oncol. 2007 Mar; 104(3):768-78.
Score: 0.006
-
Total laparoscopic radical hysterectomy: surgical technique and instrumentation. Gynecol Oncol. 2007 Feb; 104(2 Suppl 1):13-6.
Score: 0.005
-
Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. Gynecol Oncol. 2007 Jan; 104(1):100-3.
Score: 0.005
-
Usefulness of preoperative lymphoscintigraphy in patients who undergo radical hysterectomy and pelvic lymphadenectomy for cervical cancer. Am J Obstet Gynecol. 2006 Apr; 194(4):1186-93; discussion 1193-5.
Score: 0.005
-
Fertility-sparing therapy for young women with endometrial cancer. Expert Rev Anticancer Ther. 2006 Jan; 6(1):27-32.
Score: 0.005
-
Lymphatic mapping and sentinel node detection in gynecologic malignancies of the lower genital tract. Curr Oncol Rep. 2005 Nov; 7(6):435-43.
Score: 0.005
-
Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol. 2005 Oct 20; 23(30):7428-36.
Score: 0.005
-
Quality of life in cervix cancer survivors--what matters the most in the long-term? Gynecol Oncol. 2005 May; 97(2):307-9.
Score: 0.005
-
Metastatic carcinoma of the gallbladder mimicking an advanced cervical carcinoma. Gynecol Oncol. 2005 Jun; 97(3):942-5.
Score: 0.005
-
Accuracy of pre-operative tumor size assessment compared to final pathology and frequency of adjuvant treatment in patients with FIGO 2018 stage IB2 cervical cancer. Int J Gynecol Cancer. 2024 Dec 02; 34(12):1861-1866.
Score: 0.005
-
Predictors of final histology in patients with endometrial cancer. Gynecol Oncol. 2004 Dec; 95(3):463-8.
Score: 0.005
-
YAP1 Status Defines Two Intrinsic Subtypes of LCNEC with Distinct Molecular Features and Therapeutic Vulnerabilities. Clin Cancer Res. 2024 Oct 15; 30(20):4743-4754.
Score: 0.005
-
Comparative analysis of hormonal therapy in low-grade endometrial stromal sarcoma: A retrospective study. Gynecol Oncol. 2024 Dec; 191:143-149.
Score: 0.005
-
Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer. J Am Coll Surg. 2004 Sep; 199(3):388-93.
Score: 0.005
-
Laparoscopic training and practice in gynecologic oncology among Society of Gynecologic Oncologists members and fellows-in-training. Gynecol Oncol. 2004 Sep; 94(3):746-53.
Score: 0.005
-
Innovations in Rare Gynecologic Cancer: Melanoma, Neuroendocrine, and Low-Grade Serous Ovarian. Am Soc Clin Oncol Educ Book. 2024 Jun; 44(3):e431818.
Score: 0.005
-
LACC Trial: Final Analysis on Overall Survival Comparing Open Versus Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer. J Clin Oncol. 2024 Aug 10; 42(23):2741-2746.
Score: 0.005
-
Consensus on surgical technique for sentinel lymph node dissection in cervical cancer. Int J Gynecol Cancer. 2024 Apr 01; 34(4):504-509.
Score: 0.005
-
Impact of pelvic radiation therapy in patients with early neuroendocrine cervical carcinoma and no residual disease in the radical hysterectomy specimen: a NeCTuR study. Int J Gynecol Cancer. 2024 Feb 05; 34(2):209-215.
Score: 0.005
-
Molecular image-guided surgery in gynaecological cancer: where do we stand? Eur J Nucl Med Mol Imaging. 2024 Aug; 51(10):3026-3039.
Score: 0.004
-
Serial cytoreductive surgery and survival outcomes in recurrent adult-type ovarian granulosa cell tumors. Am J Obstet Gynecol. 2024 05; 230(5):544.e1-544.e13.
Score: 0.004
-
Sentinel lymph node mapping with indocyanine green using SPY-PHI in open radical hysterectomy or trachelectomy. Int J Gynecol Cancer. 2024 Jan 05; 34(1):28-34.
Score: 0.004
-
Characteristics of recurrence in patients who underwent lymphatic mapping for vulvar cancer. Gynecol Oncol. 2004 Jan; 92(1):205-10.
Score: 0.004
-
Comparing long-term sexual dysfunction across different uterine cancer treatment modalities. Brachytherapy. 2024 Jan-Feb; 23(1):1-9.
Score: 0.004
-
Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA). Pigment Cell Melanoma Res. 2023 11; 36(6):542-556.
Score: 0.004
-
Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasms. Endocr Relat Cancer. 2023 08 01; 30(8).
Score: 0.004
-
Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases. Am J Surg Pathol. 2023 06 01; 47(6):635-648.
Score: 0.004
-
Clinical outcomes of leuprolide acetate in the treatment of recurrent ovarian granulosa cell tumors. Am J Obstet Gynecol. 2023 06; 228(6):724.e1-724.e9.
Score: 0.004
-
PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG study. Int J Gynecol Cancer. 2023 02 06; 33(2):293-298.
Score: 0.004
-
Thomas Eakins' Agnew Clinic. a study of medicine through art. Obstet Gynecol. 2002 Dec; 100(6):1296-300.
Score: 0.004
-
Gynecologic tract melanoma in the contemporary therapeutic era: High rates of local and distant disease progression. Gynecol Oncol. 2022 Dec; 167(3):483-489.
Score: 0.004
-
Lymphatic Mapping and Sentinel Node Biopsy in High-Grade Uterine Cancers. Curr Oncol Rep. 2022 11; 24(11):1521-1529.
Score: 0.004
-
A Not So Perfect Score: Factors Associated with the Rate of Straight Line Scoring in Oncology Training Programs. J Cancer Educ. 2022 06; 37(3):615-620.
Score: 0.004
-
Endoscopic assessment of radiological stage IVA cervical cancer: A bivariate meta-analysis supporting an evidence-based staging algorithm proposal. Gynecol Oncol. 2022 06; 165(3):642-649.
Score: 0.004
-
Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer. Clin Cancer Res. 2021 12 01; 27(23):6354-6365.
Score: 0.004
-
ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer. Int J Gynecol Cancer. 2021 10; 31(10):1317-1325.
Score: 0.004
-
Development of a surgical competency assessment tool for sentinel lymph node dissection by minimally invasive surgery for endometrial cancer. Int J Gynecol Cancer. 2021 05; 31(5):647-655.
Score: 0.004
-
An Integrated Approach to Selecting a Prepared Medical Decision-Maker. J Pain Symptom Manage. 2021 06; 61(6):1305-1310.
Score: 0.004
-
Fertility considerations prior to conservative management of gynecologic cancers. Int J Gynecol Cancer. 2021 03; 31(3):339-344.
Score: 0.004
-
Survival After Minimally Invasive vs Open Radical Hysterectomy for Early-Stage Cervical Cancer: A Systematic Review and Meta-analysis. JAMA Oncol. 2020 07 01; 6(7):1019-1027.
Score: 0.004
-
Coronavirus (COVID-19): Patient experience-Administrative services on the frontline during crisis. Head Neck. 2020 Jul; 42(7):1477-1481.
Score: 0.003
-
Revised 2018 International Federation of Gynecology and Obstetrics (FIGO) cervical cancer staging: A review of gaps and questions that remain. Int J Gynecol Cancer. 2020 06; 30(6):873-878.
Score: 0.003
-
IGCS Intraoperative Technology Taskforce. Update on near infrared imaging technology: beyond white light and the naked eye, indocyanine green and near infrared technology in the treatment of gynecologic cancers. Int J Gynecol Cancer. 2020 05; 30(5):670-683.
Score: 0.003
-
COVID-19 Global Pandemic: Options for Management of Gynecologic Cancers. Int J Gynecol Cancer. 2020 05; 30(5):561-563.
Score: 0.003
-
Phase 2 study of pembrolizumab in patients with advanced rare cancers. J Immunother Cancer. 2020 03; 8(1).
Score: 0.003
-
Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002). Gynecol Oncol. 2020 04; 157(1):161-166.
Score: 0.003
-
Implementation of a sentinel lymph node mapping algorithm for endometrial cancer: surgical outcomes and hospital charges. Int J Gynecol Cancer. 2020 03; 30(3):352-357.
Score: 0.003
-
Systematic Approach to Selecting and Preparing a Medical Power of Attorney in the Gynecologic Oncology Center. J Oncol Pract. 2019 12; 15(12):e1092-e1097.
Score: 0.003
-
Incidence of adverse events in minimally invasive vs open radical hysterectomy in early cervical cancer: results of a randomized controlled trial. Am J Obstet Gynecol. 2020 03; 222(3):249.e1-249.e10.
Score: 0.003
-
Preoperative PET/CT does not accurately detect extrauterine disease in patients with newly diagnosed high-risk endometrial cancer: A prospective study. Cancer. 2019 10 01; 125(19):3347-3353.
Score: 0.003
-
An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor. Gynecol Oncol. 2019 06; 153(3):541-548.
Score: 0.003
-
Volumetric assessment of apparent diffusion coefficient predicts outcome following chemoradiation for cervical cancer. Radiother Oncol. 2019 06; 135:58-64.
Score: 0.003
-
Imaging and staging of neuroendocrine cervical cancer. Abdom Radiol (NY). 2018 12; 43(12):3468-3478.
Score: 0.003
-
Perineural invasion (PNI) in vulvar carcinoma: A review of 421 cases. Gynecol Oncol. 2019 01; 152(1):101-105.
Score: 0.003
-
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer. N Engl J Med. 2018 Nov 15; 379(20):1895-1904.
Score: 0.003
-
PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer. Mol Cancer Ther. 2019 01; 18(1):162-172.
Score: 0.003
-
Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy. Front Immunol. 2018; 9:2102.
Score: 0.003
-
A practical guide for the safe implementation of early phase drug development and immunotherapy program in gynecologic oncology practice. Gynecol Oncol. 2018 11; 151(2):374-380.
Score: 0.003
-
Impact of Sentinel Node Approach in Gynecologic Cancer on Training Needs. J Minim Invasive Gynecol. 2019 May - Jun; 26(4):727-732.
Score: 0.003
-
Simple trachelectomy with pelvic lymphadenectomy as a viable treatment option in pregnant patients with stage IB1 (=2?cm) cervical cancer: Bridging the gap to fetal viability. Gynecol Oncol. 2018 07; 150(1):50-55.
Score: 0.003
-
The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer. J Gynecol Oncol. 2018 Sep; 29(5):e68.
Score: 0.003
-
Radical parametrectomy after 'cut-through' hysterectomy in low-risk early-stage cervical cancer: Time to consider this procedure obsolete. Gynecol Oncol. 2018 06; 149(3):520-524.
Score: 0.003
-
Effectiveness of definitive radiotherapy for squamous cell carcinoma of the vulva with gross inguinal lymphadenopathy. Gynecol Oncol. 2018 03; 148(3):474-479.
Score: 0.003
-
Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer. Gynecol Oncol. 2018 01; 148(1):132-138.
Score: 0.003
-
Sentinel lymph node mapping in minimally invasive surgery: Role of imaging with color-segmented fluorescence (CSF). Gynecol Oncol. 2017 09; 146(3):676-677.
Score: 0.003
-
A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer. Gynecol Oncol. 2017 08; 146(2):234-239.
Score: 0.003
-
Potential immunotherapy targets in recurrent cervical cancer. Gynecol Oncol. 2017 06; 145(3):462-468.
Score: 0.003
-
Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 Cases. Clin Cancer Res. 2017 04 15; 23(8):2093-2104.
Score: 0.003
-
Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation. Int J Radiat Oncol Biol Phys. 2017 03 01; 97(3):546-553.
Score: 0.003
-
Utility of indocyanine green (ICG) intra-operative angiography to determine uterine vascular perfusion at the time of radical trachelectomy. Gynecol Oncol. 2016 Nov; 143(2):357-361.
Score: 0.003
-
Role of Indocyanine Green in Sentinel Node Mapping in Gynecologic Cancer: Is Fluorescence Imaging the New Standard? J Minim Invasive Gynecol. 2016 Feb 01; 23(2):186-93.
Score: 0.003
-
Impact of Lymph Node Ratio and Adjuvant Therapy in Node-Positive Endometrioid Endometrial Cancer. Int J Gynecol Cancer. 2015 Oct; 25(8):1437-44.
Score: 0.003
-
Lymphovascular Space Invasion Portends Poor Prognosis in Low-Risk Endometrial Cancer. Int J Gynecol Cancer. 2015 Sep; 25(7):1292-9.
Score: 0.003
-
Survivors of gynecologic malignancies: impact of treatment on health and well-being. J Cancer Surviv. 2016 Apr; 10(2):261-70.
Score: 0.002
-
Feasibility of a reduced field-of-view diffusion-weighted (rFOV) sequence in assessment of myometrial invasion in patients with clinical FIGO stage I endometrial cancer. J Magn Reson Imaging. 2016 Feb; 43(2):316-24.
Score: 0.002
-
Is it equivalent? Evaluation of the clinical activity of single agent Lipodox? compared to single agent Doxil? in ovarian cancer treatment. J Oncol Pharm Pract. 2016 Aug; 22(4):599-604.
Score: 0.002
-
Role of Minimally Invasive Surgery in Gynecologic Oncology: An Updated Survey of Members of the Society of Gynecologic Oncology. Int J Gynecol Cancer. 2015 Jul; 25(6):1121-7.
Score: 0.002
-
Make New Friends But Keep the Old: Minimally Invasive Surgery Training in Gynecologic Oncology Fellowship Programs. Int J Gynecol Cancer. 2015 Jul; 25(6):1115-20.
Score: 0.002
-
Overview of the Role of Imaging in Pelvic Exenteration. Radiographics. 2015 Jul-Aug; 35(4):1286-94.
Score: 0.002
-
Radical trachelectomy in early-stage cervical cancer: A comparison of laparotomy and minimally invasive surgery. Gynecol Oncol. 2015 Sep; 138(3):585-9.
Score: 0.002
-
Radical Trachelectomy for Early-Stage Cervical Cancer: A Survey of the Society of Gynecologic Oncology and Gynecologic Oncology Fellows-in-Training. Int J Gynecol Cancer. 2015 May; 25(4):681-7.
Score: 0.002
-
Targeting those with decreased meaning and peace: a supportive care opportunity. Support Care Cancer. 2015 Jul; 23(7):2025-32.
Score: 0.002
-
Survival outcomes for patients with stage IVB vulvar cancer with grossly positive pelvic lymph nodes: time to reconsider the FIGO staging system? Gynecol Oncol. 2015 Feb; 136(2):269-73.
Score: 0.002
-
Significance of lymph node ratio in defining risk category in node-positive early stage cervical cancer. Gynecol Oncol. 2015 Jan; 136(1):48-53.
Score: 0.002
-
Overall survival after pelvic exenteration for gynecologic malignancy. Gynecol Oncol. 2014 Sep; 134(3):546-51.
Score: 0.002
-
Patient preferences for side effects associated with cervical cancer treatment. Int J Gynecol Cancer. 2014 Jul; 24(6):1077-84.
Score: 0.002
-
Summary of the 2014 MD Anderson International Meeting in Gynecologic Oncology: emerging therapies in gynecologic cancer. Gynecol Oncol. 2014 Jul; 134(1):6-9.
Score: 0.002
-
Minimally invasive surgery for endometrial cancer: does operative start time impact surgical and oncologic outcomes? Gynecol Oncol. 2014 Aug; 134(2):248-52.
Score: 0.002
-
Aggressive angiomyxomas: a comprehensive imaging review with clinical and histopathologic correlation. AJR Am J Roentgenol. 2014 Jun; 202(6):1171-8.
Score: 0.002
-
A comparison of extraperitoneal versus transperitoneal laparoscopic or robotic para-aortic lymphadenectomy for staging of endometrial carcinoma. Gynecol Oncol. 2014 Feb; 132(2):366-71.
Score: 0.002
-
Pelvic exenteration: impact of age on surgical and oncologic outcomes. Gynecol Oncol. 2014 Jan; 132(1):114-8.
Score: 0.002
-
Targeting SRC and tubulin in mucinous ovarian carcinoma. Clin Cancer Res. 2013 Dec 01; 19(23):6532-43.
Score: 0.002
-
Successful incorporation of robotic surgery into gynecologic oncology fellowship training. Gynecol Oncol. 2013 Dec; 131(3):730-3.
Score: 0.002
-
Management of low-risk early-stage cervical cancer: should conization, simple trachelectomy, or simple hysterectomy replace radical surgery as the new standard of care? Gynecol Oncol. 2014 Jan; 132(1):254-9.
Score: 0.002
-
Venous thromboembolic events in minimally invasive gynecologic surgery. J Minim Invasive Gynecol. 2013 Nov-Dec; 20(6):766-9.
Score: 0.002
-
We need a new paradigm in gynecologic cancer care: SGO proposes solutions for delivery, quality and reimbursement policies. Gynecol Oncol. 2013 Apr; 129(1):3-4.
Score: 0.002
-
Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix. Gynecol Oncol. 2013 Jun; 129(3):513-6.
Score: 0.002
-
Postoperative outcomes after continent versus incontinent urinary diversion at the time of pelvic exenteration for gynecologic malignancies. Gynecol Oncol. 2013 Jun; 129(3):580-5.
Score: 0.002
-
Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies. Gynecol Oncol. 2013 Feb; 128(2):204-8.
Score: 0.002
-
Analgesic and antiemetic requirements after minimally invasive surgery for early cervical cancer: a comparison between laparoscopy and robotic surgery. Ann Surg Oncol. 2013 Apr; 20(4):1355-9.
Score: 0.002
-
Laparoscopic radical trachelectomy. JSLS. 2012 Jul-Sep; 16(3):503-7.
Score: 0.002
-
Risk factors for prolonged hospitalization after gynecologic laparoscopic surgery. Gynecol Oncol. 2012 Sep; 126(3):428-31.
Score: 0.002
-
Impact of smoking on perioperative pulmonary and upper respiratory complications after laparoscopic gynecologic surgery. Gynecol Oncol. 2012 Jun; 125(3):556-60.
Score: 0.002
-
The effect of body mass index on surgical outcomes and survival following pelvic exenteration. Gynecol Oncol. 2012 May; 125(2):336-42.
Score: 0.002
-
Quality of laparoscopic radical hysterectomy in developing countries: a comparison of surgical and oncologic outcomes between a comprehensive cancer center in the United States and a cancer center in Colombia. Gynecol Oncol. 2012 May; 125(2):326-9.
Score: 0.002
-
Impact of surgeon volume on patient safety in laparoscopic gynecologic surgery. Gynecol Oncol. 2012 Apr; 125(1):241-4.
Score: 0.002
-
Proceedings from the 9th International Conference on Ovarian Cancer. Gynecol Oncol. 2012 Apr; 125(1):5-7.
Score: 0.002
-
Modified vertical rectus abdominis myocutaneous flap vaginal reconstruction: an analysis of surgical outcomes. Gynecol Oncol. 2012 Apr; 125(1):252-5.
Score: 0.002
-
Comparison of single-port laparoscopy, standard laparoscopy, and robotic surgery in patients with endometrial cancer. Ann Surg Oncol. 2012 May; 19(5):1583-8.
Score: 0.002
-
Robotic-assisted surgery in gynecologic oncology: a Society of Gynecologic Oncology consensus statement. Developed by the Society of Gynecologic Oncology's Clinical Practice Robotics Task Force. Gynecol Oncol. 2012 Feb; 124(2):180-4.
Score: 0.002
-
Fertility sparing surgery for treatment of early-stage cervical cancer: open vs. robotic radical trachelectomy. Gynecol Oncol. 2012 Feb; 124(2):276-80.
Score: 0.002
-
Radical hysterectomy: a comparison of surgical approaches after adoption of robotic surgery in gynecologic oncology. Gynecol Oncol. 2011 Nov; 123(2):333-6.
Score: 0.002
-
Targeting SRC in mucinous ovarian carcinoma. Clin Cancer Res. 2011 Aug 15; 17(16):5367-78.
Score: 0.002
-
Rate of port-site metastasis is uncommon in patients undergoing robotic surgery for gynecological malignancies. Int J Gynecol Cancer. 2011 Jul; 21(5):936-40.
Score: 0.002
-
Conservative management of early stage cervical cancer: is there a role for less radical surgery? Gynecol Oncol. 2011 Mar; 120(3):321-5.
Score: 0.002
-
Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer: a prospective correlation of surgical findings with positron emission tomography/computed tomography findings. Cancer. 2011 May 01; 117(9):1928-34.
Score: 0.002
-
Limited utility of magnetic resonance imaging in determining the primary site of disease in patients with inconclusive endometrial biopsy. Int J Gynecol Cancer. 2010 Nov; 20(8):1344-9.
Score: 0.002
-
Laparoendoscopic single-site surgery in gynecology: review of literature and available technology. J Minim Invasive Gynecol. 2011 Jan-Feb; 18(1):12-23.
Score: 0.002
-
Risk of thromboembolic disease in patients undergoing laparoscopic gynecologic surgery. Obstet Gynecol. 2010 Oct; 116(4):956-961.
Score: 0.002
-
Rate of vaginal cuff separation following laparoscopic or robotic hysterectomy. Gynecol Oncol. 2011 Jan; 120(1):47-51.
Score: 0.002
-
Rate of para-aortic lymph node micrometastasis in patients with locally advanced cervical cancer. Gynecol Oncol. 2010 Dec; 119(3):422-5.
Score: 0.002
-
Lymphadenectomy during endometrial cancer staging: practice patterns among gynecologic oncologists. Gynecol Oncol. 2010 Nov; 119(2):291-4.
Score: 0.002
-
Conservative surgery in early-stage cervical cancer: what percentage of patients may be eligible for conization and lymphadenectomy? Gynecol Oncol. 2010 Nov; 119(2):183-6.
Score: 0.002
-
Prevalence of lymph node metastasis in primary mucinous carcinoma of the ovary. Obstet Gynecol. 2010 Aug; 116(2 Pt 1):269-273.
Score: 0.002
-
Pelvic fractures after radiotherapy for cervical cancer: implications for survivors. Cancer. 2010 Feb 01; 116(3):625-30.
Score: 0.002
-
Microscopic evaluation of lymph-node-bearing tissue in early-stage cervical cancer: a dual-institution review. Ann Surg Oncol. 2010 Apr; 17(4):1106-10.
Score: 0.002
-
Sentinel node mapping in vulvovaginal melanoma using SPECT/CT lymphoscintigraphy. Clin Nucl Med. 2009 Dec; 34(12):859-61.
Score: 0.002
-
Vascular pseudoinvasion in laparoscopic hysterectomy specimens for endometrial carcinoma: a grossing artifact? Am J Surg Pathol. 2009 Feb; 33(2):298-303.
Score: 0.002
-
Trends in laparoscopic and robotic surgery among gynecologic oncologists: A survey update. Gynecol Oncol. 2009 Mar; 112(3):501-5.
Score: 0.002
-
Preoperative pathologic findings associated with residual disease at radical hysterectomy in women with stage IA2 cervical cancer. Gynecol Oncol. 2009 Jan; 112(1):110-3.
Score: 0.002
-
Ultrastaging improves detection of metastases in sentinel lymph nodes of uterine cervix squamous cell carcinoma. Am J Surg Pathol. 2008 Sep; 32(9):1336-43.
Score: 0.002
-
A phase III randomized clinical trial comparing laparoscopic or robotic radical hysterectomy with abdominal radical hysterectomy in patients with early stage cervical cancer. J Minim Invasive Gynecol. 2008 Sep-Oct; 15(5):584-8.
Score: 0.002
-
Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis. Gynecol Oncol. 2007 Dec; 107(3):458-63.
Score: 0.001
-
Preoperative lymph-vascular space invasion is associated with nodal metastases in women with early-stage cervical cancer. Gynecol Oncol. 2007 Jul; 106(1):12-5.
Score: 0.001
-
Therapeutic value of pretherapeutic extraperitoneal laparoscopic staging of locally advanced cervical carcinoma. Gynecol Oncol. 2007 May; 105(2):304-11.
Score: 0.001
-
Retroperitoneal lymph node resection in patients with cervical cancer. Surg Oncol. 2006 Aug; 15(2):79-83.
Score: 0.001
-
Generalizability of cancer clinical trial results: prognostic differences between participants and nonparticipants. Cancer. 2006 Jun 01; 106(11):2452-8.
Score: 0.001
-
Current perspectives on lymphatic mapping in carcinomas of the uterine corpus and cervix. J Natl Compr Canc Netw. 2006 May; 4(5):471-8.
Score: 0.001
-
Are women ready for the HPV vaccine? Gynecol Oncol. 2006 Oct; 103(1):151-4.
Score: 0.001
-
Electrothermal bipolar coagulation for pelvic exenterations. Gynecol Oncol. 2006 Sep; 102(3):534-6.
Score: 0.001
-
Quality of life and gynecologic malignancies. Curr Oncol Rep. 2005 Nov; 7(6):459-65.
Score: 0.001
-
Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Clin Cancer Res. 2005 Sep 01; 11(17):6116-26.
Score: 0.001
-
Well-differentiated papillary mesothelioma of the peritoneum: a pathological analysis and review of the literature. Gynecol Oncol. 2005 Jul; 98(1):161-7.
Score: 0.001
-
Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol. 2004 Oct; 95(1):133-8.
Score: 0.001
-
Recruitment and screening policies and procedures used to establish a paid donor oocyte registry. Hum Reprod. 1998 Jul; 13(7):2020-4.
Score: 0.001
-
The beta-core fragment of chorionic gonadotropin is not complexed to macromolecules in amniotic fluid. J Clin Endocrinol Metab. 1994 Jun; 78(6):1349-53.
Score: 0.001